Rfp-labeled Tumor Cells
Rfp-labeled Tumor Cells - Related Videos
06:07
A Novel RFP Reporter to Aid in the Visualization of the Eye Imaginal Disc in Drosophila
0 Views •
Cited by 1 •
2009
We describe a novel red fluorescent protein (RFP) reporter that is expressed specifically in the Drosophila eye. We detail a methodology for dissection of the eye imaginal disc and how this reporter can be used to aid in the dissection and identification of specific cell types in the developing eye.
03:19
Transduction to Label PDX Tumor Cells: Introducing Lentivirus Expressing Fluorescent Marker into the Tumor Cell In Vitro
0 Views •
2023
The following video describes a technique of transduction to label (patient-derived xenografts) PDX tumor cells, which is used for introducing lentivirus expressing green-fluorescent protein and luciferase reporters into the tumor cell in vitro.
09:53
Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies
0 Views •
Cited by 18 •
2016
We describe a method for stable labeling of patient-derived xenografts (PDXs) with lentiviral particles expressing green-fluorescent protein and luciferase reporters. This method allows for tracking the growth of PDXs at the primary site, as well as detecting spontaneous and experimental metastases using in vivo imaging systems.
08:01
Quantifying the Frequency of Tumor-propagating Cells Using Limiting Dilution Cell Transplantation in Syngeneic Zebrafish
0 Views •
Cited by 35 •
2011
Limiting dilution cell transplantation assays are used to determine the frequency of tumor-propagating cells. This protocol describes a method for generating syngeneic zebrafish that develop fluorescently-labeled leukemia and details how to isolate and transplant these leukemia cells at limiting dilution into the peritoneal cavity of adult zebrafish.
04:43
Fluorescently Labeled T-ALL Cells Isolation: A Method to Isolate T-ALL Cells from Adult Zebrafish
0 Views •
2023
This protocol describes the technique of isolating fluorescently labeled T-cell acute lymphoblastic leukemia (T-ALL) tumor cells from an adult zebrafish and quantifying them using trypan blue dye.
FAQs
Detection depends on the relationship between excitation and emission light. When the engineered cells receive the appropriate excitation wavelength, RFP absorbs that energy and emits red fluorescence at a different wavelength. Fluorescence microscopy or an imaging system captures this emitted signal, allowing labeled cells to be distinguished from surrounding material and followed during an experiment.
RFP labeling supplies a visible cellular marker that does not depend solely on how tumor tissue looks. The emitted red signal can help investigators identify labeled cancer cells within an experimental setting and distinguish their distribution from general tissue appearance. This added visualization supports more focused observation of tumor-cell behavior during growth, movement, invasion, or treatment studies.
Because the same labeled cancer-cell population can be visualized during an experiment, researchers can examine changes associated with tumor growth, migration, invasion, and metastasis. Repeated imaging provides a way to follow disease-related behavior rather than relying only on a single endpoint. This time-oriented view is particularly useful when comparing how tumor cells behave under different experimental conditions.
Fluorescence microscopy and other imaging systems provide the detection platforms needed to observe the red signal from labeled cells. Microscopy can support visualization in culture, while imaging systems can assist with observation in experimental models. In both cases, the detected fluorescence supplies information about where the tumor cells are and how their distribution changes during the study.
A basic workflow begins with the RFP-labeled cancer cells in culture or an experimental model. The sample is illuminated using the appropriate excitation wavelength, and the emitted red fluorescence is captured with fluorescence microscopy or an imaging system. Researchers then use the resulting observations to follow tumor-cell location or behavior and assess changes during the experiment.
Researchers can use these cells when they need to visualize cancer-cell behavior in culture or experimental models. The approach supports investigations of tumor growth, migration, invasion, metastasis, and treatment response. By making labeled cells easier to follow, it helps connect visible changes in an experimental model with disease progression and provides a way to evaluate therapeutic strategies.
RFP labeling allows investigators to monitor the labeled tumor cells while studying treatment response. Changes observed through fluorescence imaging can be used to follow the cells during an experiment and compare their behavior as a therapeutic strategy is evaluated. This visibility helps researchers examine treatment-related effects alongside broader observations of tumor progression in culture or experimental models.